• Human T-Cell Lymphotropic Virus (HTLV) I/II Antibody Screen
  • Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements, FISH, Tissue
  • Mycoplasma pneumoniae Antibody, CF (CSF)
  • Calcium, 24 Hour, Urine
  • Lysosomal Acid Lipase, Enzyme Activity
  • Tacrolimus
  • Class of Anticonvulsants
  • Cyclin-D1 (BCL1) Expression, Immunohistochemistry, Tissue
  • Rubella (German measles)
  • Leukocyte Alkaline Phosphatase
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Methodology
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.
Loading...